Elastin gene expression in elastotic human breast cancers and epithelial cell lines

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Elastosis, characterized by elastic tissue deposition, is a key feature of the desmoplastic reaction in invasive breast cancers.
• Traditionally, breast stromal fibroblasts were considered the primary source of this elastic tissue.
• Emerging evidence suggests a potential contribution from breast cancer epithelium.

Purpose of the Study:

• To investigate the cellular origin of elastin in the desmoplastic reaction of invasive breast cancers.
• To determine if breast cancer cell lines synthesize elastin and its messenger RNA (mRNA).
• To analyze the cellular localization of elastin mRNA in breast cancer tissues.

Main Methods:

• Cell culture of human breast cancer cell lines and stromal fibroblasts.
• Synthesis of tropoelastin and elastin by cultured cells.
• Northern blot analysis to detect elastin mRNA.
• In situ hybridization to localize elastin mRNA in breast cancer tissue samples.

Main Results:

• Human breast cancer cell lines synthesize immunoreactive tropoelastin and express elastin mRNA.
• Cancer cell elastin production rates were 1.6-15% of control fibroblasts.
• In situ hybridization revealed that while stromal fibroblasts are the main source, malignant epithelium contributes significantly to elastin in a proportion of breast cancers.
• Vascular endothelium also expresses the elastin gene in some cases.

Conclusions:

• Elastosis in breast cancers is a complex process with multifactorial origins, involving stromal fibroblasts, malignant epithelium, and vascular endothelium.
• The cellular source of desmoplastic elastin can vary within a single tumor.
• Subclassifying breast cancers by the cellular source of elastin may offer prognostic insights.